自適應生物技術公司
DE ˙ MUN ˙ US00650F1093
€13.58 ↑0.76 (5.89%)
2026-06-04
分享價格
SecurityDE:1HM / Adaptive Biotechnologies Corporation
InstitutionFmr Llc
Latest Disclosed Ownership567,032 shares
Latest Disclosed Value $ 7,870,399
Fmr Llc reports 46.87% increase in ownership of 1HM / Adaptive Biotechnologies Corporation

On May 15, 2026 - Fmr Llc filed a 13F-HR form disclosing ownership of 567,032 shares of Adaptive Biotechnologies Corporation (DE:1HM) valued at $6,316,736 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 386,084 shares of Adaptive Biotechnologies Corporation. This represents a change in shares of 46.87% during the quarter. The current value of the position is $7,700,295 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 567,032 180,948 46.87 7,870 25.52 0.0001
2026-02-17 2025-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 386,084 61,588 18.98 6,270 29.17 0.0003
2025-11-13 2025-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 324,496 33,388 11.47 4,854 43.14 0.0003
2025-08-14 2025-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 291,108 2,641 0.92 3,391 58.24 0.0002
2025-05-12 2025-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 288,467 32,729 12.80 2,143 39.79 0.0001
2025-02-13 2024-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 255,738 22,172 9.49 1,533 28.28 0.0001
2024-11-13 2024-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 233,566 117,965 102.04 1,196 185.89 0.0001
2024-08-13 2024-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 115,601 9,424 8.88 418 22.94 0.0000
2024-05-13 2024-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 106,177 -16 -0.02 341 -34.62 0.0000
2024-02-13 2023-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 106,193 -12,107 -10.23 520 -19.25 0.0000
2023-11-13 2023-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 118,300 5,281 4.67 645 -15.04 0.0001
2023-08-11 2023-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 113,019 21,835 23.95 758 -5.84 0.0001
2023-08-11 2023-03-31 13F/A-1 ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 91,184 60 0.07 805 15.66 0.0001
2023-05-11 2023-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 91,184 60 805 0.0000
2023-02-13 2022-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 91,124 4,012 4.61 696 12.26 0.0001
2022-11-10 2022-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 87,112 74,621 597.40 620 513.86 0.0001
2022-08-12 2022-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 12,491 6,301 101.79 101 17.44 0.0000
2022-05-13 2022-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 6,190 -1,138,262 -99.46 86 -99.73 0.0000
2022-02-14 2021-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 1,144,452 1,143,169 89,101.25 32,113 72,884.09 0.0024
2022-02-14 2021-09-30 13F/A-1 ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 1,283 -26,184 -95.33 44 -96.08 0.0000
2021-11-15 2021-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 1,283 -26,184 44 0.0000
2021-08-13 2021-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 27,467 -317,656 -92.04 1,123 -91.92 0.0001
2021-05-14 2021-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 345,123 -1,656,127 -82.75 13,895 -88.26 0.0012
2021-02-08 2020-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 2,001,250 1,022,838 104.54 118,335 148.71 0.0105
2020-11-13 2020-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 978,412 603,311 160.84 47,580 162.18 0.0048
2020-08-24 2020-06-30 13F/A-1 ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 375,101 -87,080 -18.84 18,148 41.34 0.0020
2020-08-13 2020-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 375,101 -87,080 18,148 445.8433
2020-05-14 2020-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 462,181 -55,048 -10.64 12,840 -17.03 0.0018
2020-02-07 2019-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 517,229 30,426 6.25 15,475 2.88 0.0017
2019-11-13 2019-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 486,803 -119,597 -19.72 15,042 -48.64 0.0018
2019-08-13 2019-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 606,400 606,400 29,289 0.0034
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.